....CHDE......GB....LI..............................................................................*EPregister to ST.36 EBD process v 1.0 kbaumeister@epo.org (15 Jan 2013)0964694A119991222EP97946409.01997102419990525enenen1996073826219961025US1999122219995119991222199951

A01K 67/ 027 A I

A61K 31/ 711 A I

A61K 35/ 26 A I

A61K 35/ 37 A I

A61K 38/ 00 A I

A61K 38/ 17 A I

A61K 39/ 395 A I

A61K 48/ 00 A I

A61P 35/ 00 A I

A61P 37/ 04 A I

A61P 37/ 06 A I

C07K 14/ 47 A I

C07K 16/ 18 A I

C12N 5/ 10 A I

C12N 15/ 09 A I

enMUCIN-MEDIATED IMMUNOMODULATIONfrIMMUNOMODULATION INDUITE PAR LA MUCINEdeMUCIN-VERMITTELTE IMMUNOMODULATIONDANA-FARBER CANCER INSTITUTE, INC.44 Binney StreetBoston, MA 02115USGONG, Jianlin20 Winchester Street 7Brookline, MA 02146USKUFE, Donald179 Grove StreetWellesley, MA 02181USDzieglewska, Hanna EvaFrank B. Dehn & Co., European Patent Attorneys, 179 Queen Victoria StreetLondon EC4V 4ELGBCHDEGBLIUS199701978419971024enWO199801730019980430199817